PX'Therapeutics expands manufacturing site
PX'Therapeutics SA, formerly called Protein'eXpert, has set up an additional biomanufacturing unit dedicated to producing therapeutic proteins and monoclonal antibodies in mammalian cells.
Archives for November 25, 2009
Norvartis’ US cell vacc plant could make adjuvant in December
Novartis says its new cell culture plant in Holly Springs, North Carolina could begin making its flu vaccine boosting MF59 adjuvant as early as next month if approved by US regulators.
USP revises vial labelling standard
The USP has clarified its proposed revision to the labelling of injectable drug vials which states that ferrules and cap overseals can only have markings intended to prevent an imminent life-threatening situation.
Pfizer to build R&D capacity in China
Pfizer will expand its clinical services and biomedical presence in China as part of a worldwide effort to develop its R&D infrastructure.
CMO market worth $33.7bn by 2014
The market for contract manufacturing organisations (CMO) will be worth $33.7bn (€22.4bn) by 2014, according to a report which says developing biologics capabilities is a key imperative for growth.
NexMed to buy CRO Bio-Quant to boost Nasdaq compliance bid
US pharmaceutical firm NexMed hopes the planned acquisition of preclinical CRO Bio-Quant will help maintain its Nasdaq listing.
Lonza to make trial stocks of Micromet cancer MAb
Lonza will produce trial supplies of Micromet’s candidate blood cancer treatment blinatumomab under a contract announced today.